DataLibraryResearch is tracking the market dynamics of the crisis in the Pharma & Healthcare industry amid lock-down changes in the supply chain.

Get detailed analysis of the COVID-19 impact on the Human Embryonic Stem Cells (HESC) Market

Global Human Embryonic Stem Cells (HESC) Market Opportunities and Forecast 2020-2027

  • DLR2728
  • 13 August, 2021
  • Pharma & Healthcare
  • Pages: 120
  • Global
Global Human Embryonic Stem Cells (HESC) Market, By Type (Totipotent Stem Cell, Pluripotent Stem Cell, and Unipotent Stem Cell), By Application (Regenerative medicine, Stem cell biology research, Tissue engineering, and Toxicology testing), and opportunities and forecast 2020-2027

Human Embryonic Stem Cells (HESC) Market Overview

The global Human Embryonic Stem Cells (HESC) market is expected to grow at a moderate rate during the forecast period. Growing incidences of genetic disorders is boosting the growth of the global Human Embryonic Stem Cells (HESC) market. An increasing number of research projects for the development of human embryonic stem cells to expand the growth of the market.

Moreover, governments in many countries are supporting and taking initiatives for the research in human embryonic stem cell development in the healthcare sector is the important factor expected to boost the growth of the Human Embryonic Stem Cells (HESC) market in near future. In addition to this, growing health care expenditure is further driving the expansion of this market globally.

On the other hand, a lack of awareness among patients and the high cost of the research along with the challenges associated with the handling and use of human embryonic stem cells is likely to hamper the global Human Embryonic Stem Cells (HESC) market during the forecast period.

Covid-19 Impact on Human Embryonic Stem Cells (HESC) Market:

In addition, the current Human Embryonic Stem Cells (HESC) Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Human Embryonic Stem Cells (HESC) Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.

The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.

Human Embryonic Stem Cells (HESC) Market Segment Overview

According to Type, the market is segmented into Totipotent Stem Cell, Pluripotent Stem Cell, and Unipotent Stem Cell. Among these Totipotent Stem Cell holds the largest share of the market mainly because of the growing research and development of the applications of human embryonic stem cells for bringing up multicellular organisms. This growth in R&D would propel the growth of the segment during the forecast period.

Based on application, the market is segmented into Regenerative medicine, Stem cell biology research, Tissue engineering, and Toxicology testing. In addition, the Regenerative medicine segment are expected to grow at the highest rate in the coming years. This owes to the advantages posed by the segment which includes, promoting the repair response of diseased, dysfunctional or injured tissue using stem cells thus it boosting the demand for Human Embryonic Stem Cells (HESC) globally.

Market Analysis, Insights and Forecast – By Type

·       Totipotent Stem Cell
·       Pluripotent Stem Cell
·       Unipotent Stem Cell

Market Analysis, Insights and Forecast – By Application

·       Regenerative medicine
·       Stem cell biology research
·       Tissue engineering
·       Toxicology testing

Human Embryonic Stem Cells (HESC) Market Regional Overview

Region-wise, North America dominated the global Human Embryonic Stem Cells (HESC) market and is expected to continue its dominance during the forecast period. Factors such as the presence of numerous prominent entities incorporated in the U.S., and high health care expenditure propels the growth of the market in North America. Similarly, Asia Pacific is also expected to account for the fastest growth in the global market owing to well-established health care infrastructure. Factors such as development in the health care infrastructure, rising awareness about health, a surge in investment in pharmaceuticals and biotechnology sectors, and growing adoption of human embryonic stem cells are expected to escalate the growth of the Human Embryonic Stem Cells (HESC) market in the Asia Pacific region.

Human Embryonic Stem Cells (HESC) Market, By Geography

·       North America (US & Canada)
·       Europe (UK, Germany, France, Italy, Spain, & Rest of Europe)
·       Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
·       LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)

Human Embryonic Stem Cells (HESC) Market Competitor overview

Some key developments and strategies adopted by manufacturers in the Human Embryonic Stem Cells (HESC) are highlighted below.

·       Invitrogen, and Novocell had announced the launch of a new fully-defined, serum- and feeder-free media specifically formulated for the growth and expansion of human embryonic stem cells (hESCs). The product, known as STEMPRO hESC SFM, will be sold by Invitrogen under a licensing agreement with Novocell.

Human Embryonic Stem Cells (HESC) Market, Key Players

·       Astellas Institute of Regenerative Medicine
·       Asterias Biotherapeutics Inc.
·       BD Biosciences
·       Cell Cure Neurosciences Ltd. (Israel)
·       Cellular Dynamics International
·       GE Healthcare (UK)
·       MilliporeSigma
·       PerkinElmer Inc.
·       Reliance Life Sciences Ltd. (India)
·       Research and Diagnostics Systems Inc.
·       SABiosciences Corp.

Human Embryonic Stem Cells (HESC) Market Study Global Market Analysis, Insights and Forecast, 2020-2027

    1. Introduction

    • 1.1. Research Scope
    • 1.2. Market Segmentation
    • 1.3. Research Methodology
    • 1.4. Definitions and Assumptions

    2. Executive Summary

      3. Market Dynamics

      • 3.1. Market Drivers
      • 3.2. Market Restraints
      • 3.3. Market Opportunities

      4. Key Insights

      • 4.1. Key Emerging Trends – For Major Countries
      • 4.2. Latest Technological Advancement
      • 4.3. Regulatory Landscape
      • 4.4. Industry SWOT Analysis
      • 4.5. Porters Five Forces Analysis

      5. Global Human Embryonic Stem Cells (HESC) Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 5.1. Key Findings / Summary
      • 5.2. Market Analysis, Insights and Forecast – By Type
        • 5.2.1. Totipotent Stem Cell
        • 5.2.2. Pluripotent Stem Cell
        • 5.2.3. Unipotent Stem Cell
      • 5.3. Market Analysis, Insights and Forecast – By Application
        • 5.3.1. Regenerative medicine
        • 5.3.2. Stem cell biology research
        • 5.3.3. Tissue engineering
        • 5.3.4. Toxicology testing
      • 5.4. Market Analysis, Insights and Forecast – By Region
        • 5.4.1. North America
        • 5.4.2. Europe
        • 5.4.3. Asia Pacific
        • 5.4.4. Latin America, Middle East, and Africa

      6. North America Human Embryonic Stem Cells (HESC) Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 6.1. Key Findings / Summary
      • 6.2. Market Analysis, Insights and Forecast – By Type
        • 6.2.1. Totipotent Stem Cell
        • 6.2.2. Pluripotent Stem Cell
        • 6.2.3. Unipotent Stem Cell
      • 6.3. Market Analysis, Insights and Forecast – By Application
        • 6.3.1. Regenerative medicine
        • 6.3.2. Stem cell biology research
        • 6.3.3. Tissue engineering
        • 6.3.4. Toxicology testing
      • 6.4. Market Analysis, Insights and Forecast – By Country
        • 6.4.1. U.S.
        • 6.4.2. Canada

      7. Europe Human Embryonic Stem Cells (HESC) Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 7.1. Key Findings / Summary
      • 7.2. Market Analysis, Insights and Forecast – By Type
        • 7.2.1. Totipotent Stem Cell
        • 7.2.2. Pluripotent Stem Cell
        • 7.2.3. Unipotent Stem Cell
      • 7.3. Market Analysis, Insights and Forecast – By Application
        • 7.3.1. Regenerative medicine
        • 7.3.2. Stem cell biology research
        • 7.3.3. Tissue engineering
        • 7.3.4. Toxicology testing
      • 7.4. Market Analysis, Insights and Forecast – By Country
        • 7.4.1. UK
        • 7.4.2. Germany
        • 7.4.3. France
        • 7.4.4. Italy
        • 7.4.5. Spain
        • 7.4.6. Russia
        • 7.4.7. Rest of Europe

      8. Asia Pacific Human Embryonic Stem Cells (HESC) Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 8.1. Key Findings / Summary
      • 8.2. Market Analysis, Insights and Forecast – By Type
        • 8.2.1. Totipotent Stem Cell
        • 8.2.2. Pluripotent Stem Cell
        • 8.2.3. Unipotent Stem Cell
      • 8.3. Market Analysis, Insights and Forecast – By Application
        • 8.3.1. Regenerative medicine
        • 8.3.2. Stem cell biology research
        • 8.3.3. Tissue engineering
        • 8.3.4. Toxicology testing
      • 8.4. Market Analysis, Insights and Forecast – By Country
        • 8.4.1. China
        • 8.4.2. India
        • 8.4.3. Japan
        • 8.4.4. Australia
        • 8.4.5. South East Asia
        • 8.4.6. Rest of Asia Pacific

      9. Latin America, Middle East, and Africa Human Embryonic Stem Cells (HESC) Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 9.1. Key Findings / Summary
      • 9.2. Market Analysis, Insights and Forecast – By Type
        • 9.2.1. Totipotent Stem Cell
        • 9.2.2. Pluripotent Stem Cell
        • 9.2.3. Unipotent Stem Cell
      • 9.3. Market Analysis, Insights and Forecast – By Application
        • 9.3.1. Regenerative medicine
        • 9.3.2. Stem cell biology research
        • 9.3.3. Tissue engineering
        • 9.3.4. Toxicology testing
      • 9.4. Market Analysis, Insights and Forecast – By Country
        • 9.4.1. Brazil
        • 9.4.2. Saudi Arabia
        • 9.4.3. UAE
        • 9.4.4. Rest of LAMEA

      10. Competitive Analysis

      • 10.1. Company Market Share Analysis, 2018
      • 10.2. Key Industry Developments
      • 10.3. Company Profile
      • 10.4. SABiosciences Corp.
        • 10.4.1. Business Overview
        • 10.4.2. Segment 1 & Service Offering
        • 10.4.3. Overall Revenue
        • 10.4.4. Geographic Presence
        • 10.4.5. Recent Development
      *Similar details will be provided for the following companies
      • 10.5. Astellas Institute of Regenerative Medicine
      • 10.6. Asterias Biotherapeutics Inc.
      • 10.7. BD Biosciences
      • 10.8. Cell Cure Neurosciences Ltd. (Israel)
      • 10.9. Cellular Dynamics International
      • 10.10. GE Healthcare (UK)
      • 10.11. MilliporeSigma
      • 10.12. PerkinElmer Inc.
      • 10.13. Reliance Life Sciences Ltd. (India)

      Report You Might be Interested

      Choose License Type

      • USD
      • GBP
      • EURO
      • INR
      Credit card Logo

      Happy To Assist You

      Have a Question? email us at

      info@datalibraryresearch.com

      Or Call Us On

      US +1 360 851 1343

      IND +91 880 579 4934